| Literature DB >> 35366009 |
Abstract
Polysorbate-80 (PS80) and histidine are common excipients in vaccine and therapeutic protein formulation. A simple quantitative NMR method to measure both PS80 and histidine in human papillomavirus (HPV) virus-like particle (VLP) vaccine for aqueous and alum-containing samples is described. The new NMR method is compared to current colorimetric methods for PS80 and RP HPLC for histidine. The new NMR method is comparable to current assays with an advantage of a simpler sample treatment for PS80. The efficiency is also increased because one method can now provide two assay results instead of two separate methods. Furthermore, the NMR method can detect PS80 stability due to hydrolysis and oxidation when PS80 is stored in a stainless steel container by observing a change of its NMR line shape profile.Entities:
Keywords: HPV; NMR; histidine; polysorbate-80; stainless steel; vaccine
Mesh:
Substances:
Year: 2022 PMID: 35366009 PMCID: PMC9544792 DOI: 10.1002/elps.202100189
Source DB: PubMed Journal: Electrophoresis ISSN: 0173-0835 Impact factor: 3.595
FIGURE 1Polysorbate‐80 structure
FIGURE 2(A) NMR spectrum of PS80 and histidine in the presence of HPV VLP samples illustrating that no HPV VLP is observed; (B) the enlarged of PS80 and histidine peaks at 3.70 and 7.21 ppm, respectively used for quantitation. (C) Standard curve for histidine. (D) Standard curve for PS80
PS80 and histidine
| Lot # | % PS80 Colorimetric | % PS80 NMR | mM Histidine RP HPLC | mM Histidine NMR |
|---|---|---|---|---|
| 1 | 0.017 | 0.013 | 20.4 | 20.0 |
| 2 | 0.017 | 0.013 | 20.1 | 20.5 |
| 3 | 0.019 | 0.014 | 20.4 | 20.1 |
| 4 | 0.017 | 0.014 | 20.1 | 19.8 |
| 5 | 0.018 | 0.014 | 20.4 | 19.8 |
| 6 | 0.017 | 0.014 | 20.5 | 20.1 |
| 7 | 0.016 | 0.013 | 20.0 | 19.5 |
| 8 | 0.016 | 0.013 | 20.1 | 19.2 |
| 9 | 0.017 | 0.013 | 20.3 | 19.5 |
| 10 | 0.016 | 0.013 | 20.0 | 19.7 |
The %RSD of PS80 colorimetric is <20%, PS80 NMR is <10%, Histidine RP HPLC is <5%, and Histidine NMR is <5%.
%RSD is defined as (standard deviation/average) × 100%.
PS80 NMR in HPV samples containing‐alum adjuvant
| Lot # | % PS80 in aqueous | % PS80 in alum adjuvant | mM Histidine in aqueous | mM Histidine in alum adjuvant |
|---|---|---|---|---|
| 7 | 0.013 | 0.0064 | 19.5 | 9.84 |
| 9 | 0.013 | 0.0064 | 19.5 | 9.84 |
FIGURE 3Comparison of NMR peak at 3.70 ppm of PS80 (0.015%) in histidine buffer stored in glass (blue trace) and stainless steel (red trace) containers. The PS80 containing HPV VLP sample stored in stainless steel (green trace) and PS80 reference standard control at 0.02% (black trace)
PS80 in HPV buffer stored in glass versus stainless steel containers
| Container | Lot # | % PS80 NMR | % PS80 Colorimetric |
|---|---|---|---|
| Glass | A | 0.010 | 0.010 |
| Stainless steel | A | 0.012 | 0.0032 |
| Glass | B | 0.016 | 0.016 |
FIGURE 4NMR peak at 3.70 ppm of PS80‐treated with NaOD (red trace) and compared with PS80‐containing HPV VLP stored in stainless steel (green trace) and PS80 reference standard as control (black trace)